Mandelic Acid Condensation Polymers for STD Prevention
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for reducing the risk of sexually transmitted diseases (STDs) like HIV/AIDS are not always effective, as they may interfere with natural vaginal mechanisms, have side effects, and are not consistently used, especially in heterosexual, homosexual, and bisexual relationships, and for individuals working with infected patients or biological samples.
Innovation Solution
Development of mandelic acid condensation polymers, specifically obtained through acid-catalyzed polymerization of mandelic acid under controlled conditions, which form protective agents that can be used topically or in compositions to reduce the risk of STD transmission without interfering with natural vaginal flora and with fewer side effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If barrier methods and vaginal contraceptives are used to prevent STD transmission, then the risk of STD transmission is reduced, but they may interfere with natural vaginal mechanisms and have side effects
Solution Approach 1:
The patent uses mandelic acid condensation polymers as an intermediary substance applied topically to mucosal surfaces. This polymer acts as a mediator that blocks pathogen attachment and entry into host cells without interfering with natural vaginal flora or mechanisms. The polymer serves as a protective barrier that allows natural physiological processes to continue while preventing STD transmission.
Solution Approach 2:
The patent employs mandelic acid condensation polymers with specific molecular weight ranges (600-6,000 Da) and controlled polymerization parameters to achieve optimal protective activity. By controlling the degree of polymerization and molecular weight, the invention optimizes the balance between protective effectiveness and compatibility with natural vaginal mechanisms, reducing side effects while maintaining high reliability in STD prevention.
2Reliability
If protective clothing and equipment are used by health care providers, then the risk of STD transmission is reduced, but exposure can still occur due to sudden movements, needle punctures, or aerosol generation
Solution Approach 1:
The patent applies mandelic acid condensation polymers as a preliminary protective measure on mucosal surfaces before potential exposure to bodily fluids. This pre-application creates a protective layer that remains effective even if protective clothing is compromised, providing an additional line of defense against STD transmission through needle punctures, cuts, or aerosol exposure.
3Reliability
If current safe-sex techniques are used, then STD transmission risk is reduced, but they are not always used or used properly due to carelessness, lack of knowledge, improper techniques, and unplanned sexual activity
Solution Approach 1:
The mandelic acid condensation polymer formulation is designed for simple self-application to mucosal surfaces, requiring minimal user knowledge or skill. The product can be easily applied by the user themselves, eliminating the need for complex techniques or assistance from partners, thereby improving consistent and proper usage across diverse populations and situations.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The mandelic acid condensation polymers effectively block pathogen attachment and entry into host cells, providing broad-spectrum antimicrobial activity against HIV, HSV, and other bacterial infections, including drug-resistant strains, while being easy to use and compatible with various sexual activities and medical settings.
Implementation Method 1
mandelic acid condensation polymers, specifically obtained through acid-catalyzed polymerization of mandelic acid under controlled conditions
Implementation Method 2
The mandelic acid condensation polymers effectively block pathogen attachment and entry into host cells, providing broad-spectrum antimicrobial activity against HIV, HSV, and other bacterial infections
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Disclosed herein are compounds and compositions useful for reducing the risk of infection. In particular, disclosed herein are mandelic acid condensation polymers, compositions comprising such compounds, processes for producing such compounds, and methods of using such compounds.